India Atlantic Chemicals Trading Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.48 M
as on 16-11-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 74.11%
(FY 2023)
- Profit 657.61%
(FY 2023)
- Ebitda 1061.91%
(FY 2023)
- Net Worth 30.33%
(FY 2023)
- Total Assets 98.45%
(FY 2023)
About India Atlantic Chemicals Trading
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.48 M, as per Ministry of Corporate Affairs (MCA) records.
Ramin Tabrizi and Rohan Deshmukh serve as directors at the Company.
- CIN/LLPIN
U51101MH2010PTC210349
- Company No.
210349
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does India Atlantic Chemicals Trading Private Limited offer?
India Atlantic Chemicals Trading Private Limited offers a wide range of products and services, including Edible Oil & Allied Products, Fish Oil, Common Disease Medicines, Pharmaceutical Medicine, Pharmaceutical Capsules, Flavours & Aromatics, Food Additive.
Who are the key members and board of directors at India Atlantic Chemicals Trading?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramin Tabrizi  | Director | 26-Nov-2010 | Current |
Rohan Deshmukh  | Director | 26-Nov-2010 | Current |
Financial Performance of India Atlantic Chemicals Trading.
India Atlantic Chemicals Trading Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.11% increase. The company also saw a substantial improvement in profitability, with a 657.61% increase in profit. The company's net worth Soared by an impressive increase of 30.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of India Atlantic Chemicals Trading?
In 2023, India Atlantic Chemicals Trading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at India Atlantic Chemicals Trading?
Unlock and access historical data on people associated with India Atlantic Chemicals Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of India Atlantic Chemicals Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped India Atlantic Chemicals Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
